go back

Vermont rates for HCPCS Q0173

Trimethobenzamide HCl, 250 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Insurance Carrier
Aetna
Facility/Professional
Professional
Modifier
Low / Median / High Price
$0.30 / $0.30 / $0.30
Cigna
Facility/Professional
Professional
Modifier
Low / Median / High Price
$0.84 / $0.84 / $0.87
MVP Health Care
Facility/Professional
Professional
Modifier
Low / Median / High Price
$0.84 / $0.84 / $0.87
United
Facility/Professional
Professional
Modifier
Low / Median / High Price
$0.80 / $0.84 / $1.94